Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery

Not Applicable

Completed

Conditions: Colorectal Cancer

Interventions: Drug: chemotherapy
Procedure: computed tomography
Procedure: conventional surgery
Procedure: neoadjuvant therapy
Procedure: positron emission tomography
Procedure: radionuclide imaging
Radiation: fludeoxyglucose F 18
Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2015-12-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 149

Registration Number: NCT00004891

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer

Phase 1

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: cisplatin
Drug: fluorouracil
Procedure: adjuvant therapy
Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2018-01-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT00052429

Locations: 🇺🇸
Memorial Sloan - Kettering Cancer Center, New York, New York, United States

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma

Phase 3

Completed

Conditions: Leukemia
Lymphoma

Interventions: Biological: dactinomycin
Biological: sargramostim
Drug: carmustine
Drug: cyclophosphamide
Drug: cytarabine
Drug: daunorubicin hydrochloride
Drug: doxorubicin hydrochloride
Drug: methotrexate
Drug: etoposide
Drug: mercaptopurine
Drug: prednisone
Drug: mitoxantrone hydrochloride
Drug: pegaspargase
Drug: vincristine sulfate
Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2016-02-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 170

Registration Number: NCT00002766

Locations: 🇺🇸
Stanford Cancer Center at Stanford University Medical Center, Stanford, California, United States
🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States

and more 4 locations

PET Scan in Treating Patients With Metastatic Prostate Cancer

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Procedure: positron emission tomography
Radiation: fludeoxyglucose F 18
Radiation: methionine C 11

First Posted Date: 2003-01-27

Last Posted Date: 2024-06-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 173

Registration Number: NCT00002981

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Phase 1

Completed

Conditions: Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2011-04-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00028912

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia

Phase 2

Completed

Conditions: Leukemia

Interventions: Biological: filgrastim
Biological: rituximab
Drug: cyclophosphamide
Drug: fludarabine phosphate

First Posted Date: 2003-01-27

Last Posted Date: 2017-10-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 39

Registration Number: NCT00003659

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Multiple Therapies in Treating Patients With Advanced Neuroblastoma

Phase 2

Completed

Conditions: Neuroblastoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-03-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00040872

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases

Phase 1

Completed

Conditions: Metastatic Cancer

Interventions: Drug: temozolomide
Drug: vinorelbine tartrate

First Posted Date: 2003-01-27

Last Posted Date: 2016-01-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 49

Registration Number: NCT00026494

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00002697

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma

Phase 2

Completed

Conditions: Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-04-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00030849

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

and more 2 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy